Amaxa LV Unit for engineered therapeutic cells for regenerative medicine
Grant Project Details:
Awardee:
Neil Otto, PhD
Timeframe:
2019-2020
Location:
B-MoGen Biotechnologies | Minneapolis, MN
Amount:
$100,000
Status:
In Process
View all grants awarded
Grant timeline: proposal, updates, reports
Grant Location
B-MoGen Biotechnologies
614 McKinley Pl NE
Minneapolis, MN 55413
Grant Description
The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐MoGen will utilize it’s non‐viral gene transfer technology, Tc Buster, to engineer MSCs and iPSCs as a vehicle to efficiently deliver therapeutic proteins to local sites of inflammation for the regeneration of healthy tissues.
Grant Awardee Biography
